---
title: "Teladoc Health Adds Independent Financial Expert to Board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294747502.md"
description: "Teladoc Health appointed Mark V. Anquillare, a veteran financial executive and former Verisk Analytics COO, to its board as an independent director and audit committee financial expert on August 3, 2026. This move aims to strengthen governance and strategic oversight. Meanwhile, analyst sentiment remains neutral with a $7.00 price target, citing weak technical trends and unprofitability, though positive free cash flow offers some offset."
datetime: "2026-08-03T22:36:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294747502.md)
  - [en](https://longbridge.com/en/news/294747502.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294747502.md)
---

# Teladoc Health Adds Independent Financial Expert to Board

Teladoc ( (TDOC) ) just unveiled an update.

On August 3, 2026, Teladoc Health expanded its board of directors to ten members and appointed veteran financial executive Mark V. Anquillare, the former president and chief operating officer of Verisk Analytics, to the board and to its audit and compensation committees. The board designated him an independent director and an audit committee financial expert, and confirmed there were no related-party arrangements or transactions tied to his selection.

Anquillare brings more than three decades of financial and operational leadership, including guiding Verisk through its 2009 IPO and overseeing major insurance and government-facing businesses, as well as current board roles at Guidewire Software, RegEd and Bamboo Insurance. His appointment is expected to bolster Teladoc’s governance and strategic oversight as it leverages data, technology and AI to evolve its virtual care platform, with his experience seen as supporting innovation, operating efficiency and long-term value creation for stakeholders.

The most recent analyst rating on (TDOC) stock is a Hold  
with a $7.00 price target.  
To see the full list of analyst forecasts on Teladoc stock,  
see the TDOC Stock Forecast page.

**Spark’s Take on TDOC Stock**

According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.

TDOC scores below average primarily due to weak technical trend (price below key moving averages) and still-unprofitable financial performance with a pressured revenue outlook. These are partially offset by strong, positive free cash flow and a balanced earnings update where Integrated Care margins improved and cash flow guidance held, though BetterHelp’s transition continues to weigh on near-term revenue and execution confidence.

To see Spark’s full report on TDOC stock,  
click here.

**More about Teladoc**

Teladoc Health, listed on the NYSE under the ticker TDOC, is a global leader in virtual care, providing technology-enabled healthcare services that connect patients, care providers, platforms and partners. Through relationships with health plans, employers, providers, health systems and consumers, the company focuses on expanding access, improving outcomes, extending provider capacity and lowering healthcare costs.

**Average Trading Volume:** 4,954,608

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $1.22B

Learn more about TDOC stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [TDOC.US](https://longbridge.com/en/quote/TDOC.US.md)
- [VRSK.US](https://longbridge.com/en/quote/VRSK.US.md)
- [GWRE.US](https://longbridge.com/en/quote/GWRE.US.md)

## Related News & Research

- [Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?](https://longbridge.com/en/news/296065054.md)
- [10:05 ETTeladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky](https://longbridge.com/en/news/295246888.md)
- [Essity To Buy Kenvue's Feminine Care Business In Brazil For $284 Mln](https://longbridge.com/en/news/296437506.md)
- [Essity to buy Kenvue feminine care business in Brazil for USD 284 million](https://longbridge.com/en/news/296383176.md)
- [QuadMed's Epic Gold Stars Recognition Signals a New Model for Employer-Sponsored Primary Care | QUAD Stock News](https://longbridge.com/en/news/296356549.md)